Cardiff Oncology Inc - Company Profile
Powered by 
All the sales intelligence you need on Cardiff Oncology Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Cardiff Oncology Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Cardiff Oncology Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Cardiff Oncology Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Cardiff Oncology Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Rodney S. Markin, M.D., Ph.D.
Chairman Executive BoardMr. Rodney S. Markin has been the Chairman of the company since 2020. Prior to this, he served as a Director of the company. Previously, Dr. Markin served as Chief Technology Officer and Associate Vice Chancellor for Business Development at the University of Nebraska.
Josh Muntner
Chief Financial Officer Senior ManagementMr. Josh Muntner has been the Chief Financial Officer of the company since April 6, 2026. Previously, he was the Chief Financial Officer of Imvax Inc. Prior to this, Mr. Muntner served as Chief Financial Officer of Mesoblast Ltd.
Brigitte Lindsay
Chief Accounting Officer Senior ManagementMs. Brigitte Lindsay has been the Chief Accounting Officer of the company since 2026. Previously, she served as the Senior Vice President of Finance of the company.
Roger Sidhu, MD
Chief Medical Officer Senior ManagementMr. Roger Sidhu has been the Chief Medical Officer of the company since June 2025. Previously, he was the Chief Medical Officer and acting Chief Executive Officer at Treadwell Therapeutics. Prior to this, he served as Executive Vice President and Chief Medical Officer at Roivant Sciences. Prior to that, he served as Chief Medical Officer at Eterna Therapeutics, Inc. Mr. Sidhu served as Chief Medical Officer at Cell Design Labs.
Tod Smeal, Ph.D.
Chief Scientific Officer Senior ManagementDr. Tod Smeal has been the Chief Scientific Officer of the company since 2022. Prior to this, he served as Chief Scientific Officer of Hexagon. Previously, he served as the Chief Scientific Officer of Cancer Biology of Eli Lilly.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer